Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5376)
All Articles published online
|
Apr 21, 2012 (publication date) through Nov 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Krag A, Israelsen H, Ryberg BV, Andersen KK, Bendtsen F. Safety and efficacy of Profermin® to induce remission in ulcerative colitis. World J Gastroenterol 2012; 18(15): 1773-1780 [PMID: 22553401 DOI: 10.3748/wjg.v18.i15.1773] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i15/1773.htm |
| Number | Citing Articles |
| 1 |
Erola Astó, Iago Méndez, Sergi Audivert, Andreu Farran-Codina, Jordi Espadaler. The Efficacy of Probiotics, Prebiotic Inulin-Type Fructans, and Synbiotics in Human Ulcerative Colitis: A Systematic Review and Meta-Analysis. Nutrients 2019; 11(2): 293 doi: 10.3390/nu11020293
|
| 2 |
Nasir Abbas, Mahrukh Shakil, Zeeshan Akhtar Rana, Sardar Basharat Ali, Ammad Ayub Awan, Saman Gul. A Systematic Review of the Role of Diet in Ulcerative Colitis. Cureus 2023; doi: 10.7759/cureus.39350
|
| 3 |
Aleksander Krag, Pia Munkholm, Hans Israelsen, Bjørn von Ryberg, Klaus K. Andersen, Flemming Bendtsen. Profermin is Efficacious in Patients with Active Ulcerative Colitis—A Randomized Controlled Trial. Inflammatory Bowel Diseases 2013; 19(12): 2584 doi: 10.1097/01.MIB.0000437046.26036.db
|
| 4 |
Louis J. Cohen, Judy H. Cho, Dirk Gevers, Hiutung Chu. Genetic Factors and the Intestinal Microbiome Guide Development of Microbe-Based Therapies for Inflammatory Bowel Diseases. Gastroenterology 2019; 156(8): 2174 doi: 10.1053/j.gastro.2019.03.017
|
| 5 |
Manuel Pabón-Carrasco, Lucia Ramirez-Baena, Samuel Vilar-Palomo, Aurora Castro-Méndez, Raúl Martos-García, Isabel Rodríguez-Gallego. Probiotics as a Coadjuvant Factor in Active or Quiescent Inflammatory Bowel Disease of Adults—A Meta-Analytical Study. Nutrients 2020; 12(9): 2628 doi: 10.3390/nu12092628
|
| 6 |
Axel Dignass, James O. Lindsay, Andreas Sturm, Alastair Windsor, Jean-Frederic Colombel, Mathieu Allez, Gert D'Haens, André D'Hoore, Gerassimos Mantzaris, Gottfried Novacek, Tom Öresland, Walter Reinisch, Miquel Sans, Eduard Stange, Severine Vermeire, Simon Travis, Gert Van Assche. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management. Journal of Crohn's and Colitis 2012; 6(10): 991 doi: 10.1016/j.crohns.2012.09.002
|
| 7 |
Wei-Feng Wang, Feng Zhou, Shan Xu, Yu-Liang Feng, Xiao-Yan Zhang, Qin Zhu, Qiao-Na He, Pei-Fen Zheng. Lactiplantibacillus plantarum attenuates 2,4,6-trinitrobenzenesulfonic acid-induced ulcerative colitis in rats by regulating the inflammatory response, T helper 17 immune response, and intestinal permeability. Biologia 2022; 77(9): 2667 doi: 10.1007/s11756-022-01111-w
|
| 8 |
Giovanni Cammarota, Gianluca Ianiro, Rossella Cianci, Stefano Bibbò, Antonio Gasbarrini, Diego Currò. The involvement of gut microbiota in inflammatory bowel disease pathogenesis: Potential for therapy. Pharmacology & Therapeutics 2015; 149: 191 doi: 10.1016/j.pharmthera.2014.12.006
|
| 9 |
Xiaoli Wang, Jingwen Zhao, Yuanhang Feng, Zelin Feng, Yulin Ye, Limin Liu, Guangbo Kang, Xiaocang Cao. Evolutionary Insights Into Microbiota Transplantation in Inflammatory Bowel Disease. Frontiers in Cellular and Infection Microbiology 2022; 12 doi: 10.3389/fcimb.2022.916543
|
| 10 |
Cuilan Huang, Wujuan Hao, Xuyang Wang, Renmin Zhou, Qiong Lin. Probiotics for the treatment of ulcerative colitis: a review of experimental research from 2018 to 2022. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1211271
|
| 11 |
Olga Biskou, Susanna Walter, Hans Israelsen, Martin E. Winberg, Olga Bednarska, Åsa V. Keita. ReFerm®: a postbiotic fermented oat gruel composition is reducing mast cell degranulation in the colon of patients with irritable bowel syndrome. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1408623
|
| 12 |
Luiz C Di Stasi, Celso ARA Costa, Aline Witaicenis. Products for the treatment of inflammatory bowel disease: a patent review (2013 – 2014). Expert Opinion on Therapeutic Patents 2015; 25(6): 629 doi: 10.1517/13543776.2015.1041921
|
| 13 |
Olga Bednarska, Olga Biskou, Hans Israelsen, Martin E. Winberg, Susanna Walter, Åsa V. Keita. A postbiotic fermented oat gruel may have a beneficial effect on the colonic mucosal barrier in patients with irritable bowel syndrome. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.1004084
|
| 14 |
Amal K. Mitra, Adetoun F. Asala, Shelia Malone, Malay Kanti Mridha. Effects of Probiotics in Adults with Gastroenteritis: A Systematic Review and Meta-Analysis of Clinical Trials. Diseases 2023; 11(4): 138 doi: 10.3390/diseases11040138
|
| 15 |
E. Arvidsson Nordström, C. Teixeira, C. Montelius, B. Jeppsson, N. Larsson. Lactiplantibacillus plantarum 299v (LP299V®): three decades of research. Beneficial Microbes 2021; 12(5): 441 doi: 10.3920/BM2020.0191
|
| 16 |
A. Dignass, J.O. Lindsay, A. Sturm, A. Windsor, J.-F. Colombel, M. Allez, G. d’Haens, A. d’Hoore, G. Mantzanaris, G. Novacek, T. Öresland, W. Reinisch, M. Sans, E. Stange, S. Vermeire, S. Travis, G. van Assche. Segundo consenso europeo basado en evidencia sobre el diagnóstico y manejo de la colitis ulcerosa crónica idiopática. Parte 2: tratamiento actual (versión española). Revista de Gastroenterología de México 2015; 80(1): 32 doi: 10.1016/j.rgmx.2014.10.007
|